• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

监测体内蛋白质稳定性。

Monitoring protein stability in vivo.

作者信息

Ignatova Zoya

机构信息

Biotechnologie II, Technische Universität Hamburg-Harburg, Denickestr. 15, 21073 Hamburg, Germany.

出版信息

Microb Cell Fact. 2005 Aug 24;4:23. doi: 10.1186/1475-2859-4-23.

DOI:10.1186/1475-2859-4-23
PMID:16120213
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1208943/
Abstract

Reduced protein stability in vivo is a prerequisite to aggregation. While this is merely a nuisance factor in recombinant protein production, it holds a serious impact for man. This review focuses on specific approaches to selectively determine the solubility and/or stability of a target protein within the complex cellular environment using different detection techniques. Noninvasive techniques mapping folding/misfolding events on a fast time scale can be used to unravel the complexity and dynamics of the protein aggregation process and factors altering protein solubility in vivo. The development of approaches to screen for folding and solubility in vivo should facilitate the identification of potential components that improve protein solubility and/or modulate misfolding and aggregation and may provide a therapeutic benefit.

摘要

体内蛋白质稳定性降低是聚集的前提条件。虽然这在重组蛋白生产中仅仅是一个干扰因素,但对人类却有着严重影响。本综述聚焦于使用不同检测技术在复杂细胞环境中选择性测定目标蛋白溶解度和/或稳定性的特定方法。能够在快速时间尺度上绘制折叠/错误折叠事件的非侵入性技术,可用于揭示蛋白质聚集过程的复杂性和动态性,以及改变体内蛋白质溶解度的因素。开发在体内筛选折叠和溶解度的方法,应有助于识别改善蛋白质溶解度和/或调节错误折叠及聚集的潜在成分,并可能带来治疗益处。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8851/1208943/f0e26c17e14c/1475-2859-4-23-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8851/1208943/f0e26c17e14c/1475-2859-4-23-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8851/1208943/f0e26c17e14c/1475-2859-4-23-1.jpg

相似文献

1
Monitoring protein stability in vivo.监测体内蛋白质稳定性。
Microb Cell Fact. 2005 Aug 24;4:23. doi: 10.1186/1475-2859-4-23.
2
Derivation of a solubility condition for proteins from an analysis of the competition between folding and aggregation.通过对折叠和聚集之间竞争的分析推导蛋白质的溶解度条件。
Mol Biosyst. 2010 Dec;6(12):2490-7. doi: 10.1039/c005160h. Epub 2010 Oct 18.
3
Genetic selection for protein solubility enabled by the folding quality control feature of the twin-arginine translocation pathway.通过双精氨酸转运途径的折叠质量控制特性实现蛋白质溶解度的遗传选择。
Protein Sci. 2006 Mar;15(3):449-58. doi: 10.1110/ps.051902606. Epub 2006 Feb 1.
4
Protein solubility and folding monitored in vivo by structural complementation of a genetic marker protein.通过遗传标记蛋白的结构互补在体内监测蛋白质的溶解度和折叠情况。
Nat Biotechnol. 2001 Feb;19(2):131-6. doi: 10.1038/84389.
5
M1 RNA is important for the in-cell solubility of its cognate C5 protein: Implications for RNA-mediated protein folding.M1 RNA对其同源C5蛋白在细胞内的溶解性很重要:对RNA介导的蛋白质折叠的启示。
RNA Biol. 2015;12(11):1198-208. doi: 10.1080/15476286.2015.1096487. Epub 2015 Oct 30.
6
Application of a kosmotrope-based solubility assay to multiple protein therapeutic classes indicates broad use as a high-throughput screen for protein therapeutic aggregation propensity.基于协同溶媒的溶解度测定法在多种蛋白治疗类别中的应用表明,其可广泛用作高通量筛选蛋白治疗聚集倾向的方法。
J Pharm Sci. 2013 Aug;102(8):2424-39. doi: 10.1002/jps.23618. Epub 2013 May 27.
7
From the test tube to the cell: exploring the folding and aggregation of a beta-clam protein.从试管到细胞:探索β-蛤蛋白的折叠与聚集
Biopolymers. 2007;88(2):157-63. doi: 10.1002/bip.20665.
8
Analytical approaches for assessing aggregation of protein biopharmaceuticals.用于评估蛋白生物制药聚集的分析方法。
Curr Pharm Biotechnol. 2011 Oct;12(10):1530-6. doi: 10.2174/138920111798357339.
9
Metastable, partially folded states in the productive folding and in the misfolding and amyloid aggregation of proteins.蛋白质有效折叠、错误折叠及淀粉样聚集过程中的亚稳态部分折叠态。
Cell Biochem Biophys. 2006;44(3):539-48. doi: 10.1385/CBB:44:3:539.
10
Relationship between native-state solubility and non-native aggregation of recombinant human granulocyte colony stimulating factor: practical implications for protein therapeutic development.重组人粒细胞集落刺激因子天然态溶解度与非天然聚集之间的关系:对蛋白质治疗药物开发的实际影响
Mol Pharm. 2014 Oct 6;11(10):3431-42. doi: 10.1021/mp500165j. Epub 2014 Aug 29.

引用本文的文献

1
Extending Ripley's K-Function to Quantify Aggregation in 2-D Grayscale Images.扩展瑞普利K函数以量化二维灰度图像中的聚集情况。
PLoS One. 2015 Dec 4;10(12):e0144404. doi: 10.1371/journal.pone.0144404. eCollection 2015.
2
Effects of hydrophobic macromolecular crowders on amyloid β (16-22) aggregation.疏水性大分子拥挤剂对淀粉样β蛋白(16-22)聚集的影响。
Biophys J. 2015 Jul 7;109(1):124-34. doi: 10.1016/j.bpj.2015.05.032.
3
Effects of macromolecular crowding on amyloid beta (16-22) aggregation using coarse-grained simulations.

本文引用的文献

1
Protein aggregation and neurodegenerative disease.蛋白质聚集与神经退行性疾病。
Nat Med. 2004 Jul;10 Suppl:S10-7. doi: 10.1038/nm1066.
2
A new protein conformation indicator based on biarsenical fluorescein with an extended benzoic acid moiety.一种基于带有延伸苯甲酸部分的双砷荧光素的新型蛋白质构象指示剂。
Anal Sci. 2004 Feb;20(2):273-8. doi: 10.2116/analsci.20.273.
3
Monitoring protein stability and aggregation in vivo by real-time fluorescent labeling.通过实时荧光标记在体内监测蛋白质稳定性和聚集情况。
利用粗粒化模拟研究大分子拥挤效应对淀粉样β(16-22)聚集的影响。
J Phys Chem B. 2014 Nov 26;118(47):13513-26. doi: 10.1021/jp508970q. Epub 2014 Nov 13.
4
Identification and glycerol-induced correction of misfolding mutations in the X-linked mental retardation gene CASK.X连锁智力障碍基因CASK中错误折叠突变的鉴定及甘油诱导的校正
PLoS One. 2014 Feb 5;9(2):e88276. doi: 10.1371/journal.pone.0088276. eCollection 2014.
5
Revolutionary impact of nanodrug delivery on neuroscience.纳米药物递送对神经科学的革命性影响。
Curr Neuropharmacol. 2012 Dec;10(4):370-92. doi: 10.2174/157015912804143513.
6
Why and how protein aggregation has to be studied in vivo.为什么以及如何在体内研究蛋白质聚集。
Microb Cell Fact. 2013 Feb 15;12:17. doi: 10.1186/1475-2859-12-17.
7
Genetic selection for enhanced folding in vivo targets the Cys14-Cys38 disulfide bond in bovine pancreatic trypsin inhibitor.体内增强折叠的遗传选择针对牛胰蛋白酶抑制剂的 Cys14-Cys38 二硫键。
Antioxid Redox Signal. 2011 Mar 15;14(6):973-84. doi: 10.1089/ars.2010.3712. Epub 2011 Jan 23.
8
The scientific impact of microbial cell factories.微生物细胞工厂的科学影响。
Microb Cell Fact. 2008 Dec 1;7:33. doi: 10.1186/1475-2859-7-33.
Proc Natl Acad Sci U S A. 2004 Jan 13;101(2):523-8. doi: 10.1073/pnas.0304533101. Epub 2003 Dec 30.
4
FRET-based in vivo screening for protein folding and increased protein stability.基于荧光共振能量转移的体内蛋白质折叠及蛋白质稳定性增强筛选。
J Mol Biol. 2003 Mar 14;327(1):239-49. doi: 10.1016/s0022-2836(03)00077-9.
5
Mutations that reduce aggregation of the Alzheimer's Abeta42 peptide: an unbiased search for the sequence determinants of Abeta amyloidogenesis.降低阿尔茨海默病β淀粉样蛋白42肽聚集的突变:对β淀粉样蛋白生成序列决定因素的无偏搜索。
J Mol Biol. 2002 Jun 21;319(5):1279-90. doi: 10.1016/S0022-2836(02)00399-6.
6
New biarsenical ligands and tetracysteine motifs for protein labeling in vitro and in vivo: synthesis and biological applications.用于体外和体内蛋白质标记的新型双砷配体和四半胱氨酸基序:合成及生物学应用
J Am Chem Soc. 2002 May 29;124(21):6063-76. doi: 10.1021/ja017687n.
7
In-cell NMR spectroscopy.细胞内核磁共振光谱学。
Biochemistry. 2001 Dec 4;40(48):14317-23. doi: 10.1021/bi011751w.
8
Quantitative protein stability measurement in vivo.体内蛋白质稳定性的定量测定。
Nat Struct Biol. 2001 Oct;8(10):879-82. doi: 10.1038/nsb1001-879.
9
Evaluation of parameters critical to observing proteins inside living Escherichia coli by in-cell NMR spectroscopy.通过细胞内核磁共振光谱法评估对观察活的大肠杆菌内蛋白质至关重要的参数。
J Am Chem Soc. 2001 Sep 19;123(37):8895-901. doi: 10.1021/ja0112846.
10
High-resolution macromolecular NMR spectroscopy inside living cells.活细胞内的高分辨率大分子核磁共振光谱学。
J Am Chem Soc. 2001 Mar 14;123(10):2446-7. doi: 10.1021/ja0057528.